Basic Information
Advanced BioDesign is a preclinical-stage biotechnology company established in 2010, dedicated to developing novel anti-cancer drugs with a particular focus on utilizing ALDH as a therapeutic approach for acute myeloid leukemia and other cancers with unmet medical needs.Advanced BioDesign’s innovative strategy aims to overcome tumor chemoresistance and restore or activate endogenous cell death mechanisms in cancer cells.The company’s lead candidate drug, ABD-3001, is a small molecule inhibitor of the ALDH enzyme family, currently in the early stages of clinical development for the treatment of various cancers, including acute myeloid leukemia, non-small cell lung cancer, melanoma, and others.